Mar/Apr 2025 - Volume 29, Number 2

Purchase or view individual articles by selecting the article in the table below...

Individual Articles - Mar/Apr 2025 - Volume 29, Number 2

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2025 Pg. 90	Prescription - The Architecture of Compounding: Building a Stronger Future Author(s): Kupiec Thomas C
Mar/Apr 2025 Pg. 92-94	Let’s Talk About Outside Sales Reps for Compounding Pharmacies Author(s): Roberts Jerrod
Mar/Apr 2025 Pg. 96-103	Current Problems of Pharmaceutical Compounding in Hungary Author(s): Dobson Szabolcs
Mar/Apr 2025 Pg. 104-110	Advertising and Marketing for Compounding Pharmacies: Many Shades of Grey Author(s): Hobbs Amanda F, Howard Brad
Mar/Apr 2025 Pg. 112-115	Book Review of The Chapter <795> Answer Book 2nd Edition Author(s): Fredrickson Mary E, Schreffler Rebecca
Mar/Apr 2025 Pg. 116-119	New USP Chapters <72> and <86> for Testing Pharmaceuticals for Sterility and Endotoxins Author(s): Ashworth Lisa D
Mar/Apr 2025 Pg. 120	Calculations - Potassium Phosphate and Sodium Phosphate Oral Tablets Author(s): Stockton Shelly J
Mar/Apr 2025 Pg. 121	Erratum - Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration Author(s):
Mar/Apr 2025 Pg. 122	Atropine Sulfate 1% Ophthalmic Solution Author(s):
Mar/Apr 2025 Pg. 123-124	Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Gel Author(s):
Mar/Apr 2025 Pg. 125	Chlorothiazide 50-mg/mL Oral Suspension Author(s):
Mar/Apr 2025 Pg. 126	Folic Acid 1-mg/mL Oral Liquid Author(s):
Mar/Apr 2025 Pg. 127	Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide-Magnesium Hydroxide-Simethicone Mouthwashes Author(s):
Mar/Apr 2025 Pg. 128	Tetracaine Hydrochloride 2% Topical Solution Author(s):
Mar/Apr 2025 Pg. 129	Tobramycin Fortified 13.5-mg/mL Ophthalmic Solution Author(s):
Mar/Apr 2025 Pg. 130	Topiramate 6-mg/mL Oral Suspension Author(s):
Mar/Apr 2025 Pg. 131	Vancomycin 31-mg/mL Ophthalmic Solution Author(s):
Mar/Apr 2025 Pg. 132-140	Formulation and Characterization of Ophthalmic in Situ Gel Forming Solution of Timolol Maleate for Glaucoma Author(s): Rajagopal Kumaravelrajan, Kanmani Gokul, Venkatesan Suba, Palanivelu Amudha
Mar/Apr 2025 Pg. 141-149	Long-term Physicochemical Stability of a Pharmaceutical Preparation of Morphine Hydrochloride and Droperidol in Polypropylene Syringes Author(s): Nobels Amandine, Closset Mélanie, Bihin B, Jamart Jacques, Soumoy Laura, Lombet Louise, Hecq Jean-Daniel, Galanti Laurence, Colsoul Marie-Lise, Catry Emilie
Mar/Apr 2025 Pg. 150-162	Compatibility of Active Pharmaceutical Ingredients Combinations Compounded in Cleoderm™, a Cream Base for Personalized Dermatological Treatments Author(s): Marianni Bruna, Silva Carolina Costa Vicente, Polonini Hudson
Mar/Apr 2025 Pg. 163-175	Assessing the Compatibility of Different Formulations in OrPhyllo™, A Ready-to-Use Base for Personalized Orodispersible Films Author(s): Marianni Bruna, Polonini Hudson, Koulouridas Savvas